Taking Famotidine When Testing for H. pylori
Famotidine (Pepcid) should be stopped for at least 2 weeks before H. pylori testing when using culture, histology, rapid urease test, urea breath test (UBT), or stool antigen test, as it can lead to false-negative results. 1
Effect of Famotidine on H. pylori Testing
Impact on Test Accuracy
- H2-receptor antagonists like famotidine can cause false-negative results in H. pylori diagnostic tests, though to a lesser extent than proton pump inhibitors (PPIs) 1
- By increasing gastric pH, famotidine leads to local changes in the stomach that decrease the bacterial load, especially in the antrum 1
- This reduction in bacterial load can result in false-negative results for most diagnostic tests 1
Different Tests and Their Susceptibility to Interference
Tests affected by famotidine use:
Test not affected by famotidine:
Recommendations for Testing
When to Stop Famotidine
- Stop famotidine at least 2 weeks before testing to allow bacteria to repopulate the stomach 1
- This waiting period allows previously negative tests (UBT, SAT, rapid urease test, histology, culture) to become positive again 1
Alternative Testing Options
- If stopping famotidine is not possible, validated IgG serology can be performed instead 1
- When using the urea breath test with citric acid as the test meal, the panel did not find it necessary to stop H2-receptor antagonists before testing 1, 2
Clinical Considerations
Special Situations
- For patients who cannot stop famotidine due to symptom management needs, serology is the preferred testing method 1
- Only validated commercial serological tests with >90% accuracy should be used 1
Common Pitfalls
- Failing to recognize that H2-receptor antagonists like famotidine can cause false-negative results, though the effect is less pronounced than with PPIs 2
- Not allowing sufficient washout time before testing, which can lead to misdiagnosis and inappropriate management 1
- Using rapid in-office serological tests, which have limited accuracy compared to laboratory ELISA tests 1
By following these evidence-based recommendations, clinicians can avoid false-negative results and ensure accurate diagnosis of H. pylori infection, which is crucial for appropriate patient management and treatment.